{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:23:13Z","timestamp":1790360593509,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.psychres.2005.10.010","type":"journal-article","created":{"date-parts":[[2006,7,12]],"date-time":"2006-07-12T13:34:59Z","timestamp":1152711299000},"page":"303-306","source":"Crossref","is-referenced-by-count":36,"title":["Niacin skin flushing in schizophrenic and depressed patients and healthy controls"],"prefix":"10.1016","volume":"143","author":[{"given":"Linda","family":"Bosveld-van Haandel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikus","family":"Knegtering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Kluiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2005.10.010_bib1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0006-3223(87)90164-8","article-title":"Increased plasma phospholipase-A activity in schizophrenic patients: reduction after neuroleptic therapy","volume":"22","author":"Gattaz","year":"1987","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2005.10.010_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-9964(94)00060-L","article-title":"Increased platelet phospholipase A2 activity in schizophrenia","volume":"16","author":"Gattaz","year":"1995","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2005.10.010_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0920-9964(94)90084-1","article-title":"A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases","volume":"12","author":"Glen","year":"1994","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2005.10.010_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0920-9964(97)00151-5","article-title":"The membrane phospholipids hypothesis as a biochemical basis for the developmental concept of schizophrenia","volume":"30","author":"Horrobin","year":"1998","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2005.10.010_bib5","series-title":"Phospholipids Spectrum Disorder in Psychiatry","first-page":"3","article-title":"The phospholipid concept of psychiatric disorders and its relationship to the neurodevelopmental concept of schizophrenia","author":"Horrobin","year":"1999"},{"key":"10.1016\/j.psychres.2005.10.010_bib6","first-page":"99A","article-title":"Altered membrane phospholipids in fibroblasts from schizophrenic patients","volume":"33","author":"Kelkar","year":"1993","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2005.10.010_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0920-9964(94)90048-5","article-title":"Plasma membrane phospholipid and cholesterol distribution in skin fibroblasts form drug-naive patients at the onset of psychosis","volume":"13","author":"Mahadik","year":"1994","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2005.10.010_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.psychres.2005.10.010_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0920-9964(02)00311-0","article-title":"The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study","volume":"62","author":"Messamore","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2005.10.010_bib10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12499963","article-title":"Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans","volume":"98","author":"Morrow","year":"1992","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.psychres.2005.10.010_bib11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1742-1241.2001.tb11065.x","article-title":"The niacin skin flush test in schizophrenia: a replication study","volume":"66","author":"Puri","year":"2001","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.psychres.2005.10.010_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0278-5846(01)00220-2","article-title":"A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia","volume":"26","author":"Puri","year":"2002","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2005.10.010_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-8993(99)01123-3","article-title":"Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia","volume":"821","author":"Ross","year":"1999","journal-title":"Brain Research"},{"key":"10.1016\/j.psychres.2005.10.010_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-3956(03)00006-2","article-title":"Potential use of the topical niacin skin test in early psychosis\u2014combined approach using optical reflection spectroscopy and descriptive rating scale","volume":"37","author":"Smesny","year":"2003","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.psychres.2005.10.010_bib15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jpsychires.2004.01.007","article-title":"The influence of age and gender on niacin skin test results \u2014 implications for the use as a biochemical marker in schizophrenia","volume":"38","author":"Smesny","year":"2004","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.psychres.2005.10.010_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(02)00281-5","article-title":"Increased phospholipase A2 activity in schizophrenia with absent response to niacin","volume":"61","author":"Tavares","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2005.10.010_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0920-9964(00)00082-7","article-title":"An animal model of nicotinic-acid-induced vasodilatation: effect of haloperidol, caffeine and nicotine upon nicotinic acid response","volume":"50","author":"Turenne","year":"2001","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2005.10.010_bib18","series-title":"Phospholipids Spectrum Disorder in Psychiatry","first-page":"139","article-title":"The phospholipid concept of psychiatric disorders and its relationship to the neurodevelopmental concept of schizophrenia","author":"Ward","year":"1999"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178105003483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178105003483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T01:24:07Z","timestamp":1683509047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178105003483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":18,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0165178105003483"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2005.10.010","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}